Literature DB >> 17548469

Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification.

Noboru Taniguchi1, Kenji Yoshida, Tatsuo Ito, Masanao Tsuda, Yasunori Mishima, Takayuki Furumatsu, Lorenza Ronfani, Kazuhiro Abeyama, Ko-ichi Kawahara, Setsuro Komiya, Ikuro Maruyama, Martin Lotz, Marco E Bianchi, Hiroshi Asahara.   

Abstract

High mobility group box 1 protein (HMGB1) is a chromatin protein that has a dual function as a nuclear factor and as an extracellular factor. Extracellular HMGB1 released by damaged cells acts as a chemoattractant, as well as a proinflammatory cytokine, suggesting that HMGB1 is tightly connected to the process of tissue organization. However, the role of HMGB1 in bone and cartilage that undergo remodeling during embryogenesis, tissue repair, and disease is largely unknown. We show here that the stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. We analyzed the skeletal development of Hmgb1(-/-) mice during embryogenesis and found that endochondral ossification is significantly impaired due to the delay of cartilage invasion by osteoclasts, osteoblasts, and blood vessels. Immunohistochemical analysis revealed that HMGB1 protein accumulated in the cytosol of hypertrophic chondrocytes at growth plates, and its extracellular release from the chondrocytes was verified by organ culture. Furthermore, we demonstrated that the chondrocyte-secreted HMGB1 functions as a chemoattractant for osteoclasts and osteoblasts, as well as for endothelial cells, further supporting the conclusion that Hmgb1(-/-) mice are defective in cell invasion. Collectively, these findings suggest that HMGB1 released from differentiating chondrocytes acts, at least in part, as a regulator of endochondral ossification during osteogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548469      PMCID: PMC1952123          DOI: 10.1128/MCB.00130-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

Review 1.  Matrix metalloproteinases: effectors of development and normal physiology.

Authors:  T H Vu; Z Werb
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

2.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

3.  Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion.

Authors:  Ju Ho Youn; Jeon-Soo Shin
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro.

Authors:  F Binette; D P McQuaid; D R Haudenschild; P C Yaeger; J M McPherson; R Tubo
Journal:  J Orthop Res       Date:  1998-03       Impact factor: 3.494

5.  Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation.

Authors:  M Passalacqua; M Patrone; G B Picotti; M Del Rio; B Sparatore; E Melloni; S Pontremoli
Journal:  Neuroscience       Date:  1998-02       Impact factor: 3.590

6.  Chondrocyte-derived apoptotic bodies and calcification of articular cartilage.

Authors:  S Hashimoto; R L Ochs; F Rosen; J Quach; G McCabe; J Solan; J E Seegmiller; R Terkeltaub; M Lotz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

7.  Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice.

Authors:  V Lefebvre; S Garofalo; G Zhou; M Metsäranta; E Vuorio; B De Crombrugghe
Journal:  Matrix Biol       Date:  1994-08       Impact factor: 11.583

8.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

9.  Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones.

Authors:  M T Engsig; Q J Chen; T H Vu; A C Pedersen; B Therkidsen; L R Lund; K Henriksen; T Lenhard; N T Foged; Z Werb; J M Delaissé
Journal:  J Cell Biol       Date:  2000-11-13       Impact factor: 10.539

10.  Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM).

Authors:  S Imai; M Kaksonen; E Raulo; T Kinnunen; C Fages; X Meng; M Lakso; H Rauvala
Journal:  J Cell Biol       Date:  1998-11-16       Impact factor: 10.539

View more
  47 in total

1.  High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.

Authors:  Yoko Oyama; Teruto Hashiguchi; Noboru Taniguchi; Salunya Tancharoen; Tomonori Uchimura; Kamal K Biswas; Ko-Ichi Kawahara; Takao Nitanda; Yoshihisa Umekita; Martin Lotz; Ikuro Maruyama
Journal:  Lab Invest       Date:  2010-03-15       Impact factor: 5.662

2.  Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice.

Authors:  Ru Liu-Bryan; Robert Terkeltaub
Journal:  Arthritis Rheum       Date:  2010-07

3.  Downregulation of high mobility group protein box-1 resensitizes ovarian cancer cells to carboplatin.

Authors:  Wen Shu
Journal:  Oncol Lett       Date:  2018-07-30       Impact factor: 2.967

Review 4.  Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting.

Authors:  Georgina S Butler; Christopher M Overall
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

Review 5.  Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint.

Authors:  Niamh Fahy; Eric Farrell; Thomas Ritter; Aideen E Ryan; J Mary Murphy
Journal:  Tissue Eng Part B Rev       Date:  2014-08-04       Impact factor: 6.389

6.  Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.

Authors:  Ruiguang Zhang; Yan Li; Zhongliang Wang; Lingjuan Chen; Xiaorong Dong; Xiu Nie
Journal:  Tumour Biol       Date:  2015-06-04

Review 7.  The danger from within: alarmins in arthritis.

Authors:  Meriam Nefla; Dirk Holzinger; Francis Berenbaum; Claire Jacques
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

Review 8.  Bone and the innate immune system.

Authors:  Julia F Charles; Mary C Nakamura
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

Review 9.  HMGB proteins and arthritis.

Authors:  Noboru Taniguchi; Yasuhiko Kawakami; Ikuro Maruyama; Martin Lotz
Journal:  Hum Cell       Date:  2017-09-15       Impact factor: 4.174

Review 10.  Cartilage homeostasis in health and rheumatic diseases.

Authors:  Mary B Goldring; Kenneth B Marcu
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.